de Souza Camila Azzolin, Dos Santos Gislaine, Saldanha Schaienni Fontoura, Souza Luca Angi, da Silveira Juliano Coelho
Departamento de Medicina Veterinária, Faculdade de Zootecnia e Engenharia de Alimentos - FZEA, Universidade de São Paulo - USP, Pirassununga, SP, Brasil.
Departamento de Reproducción Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria - INIA, Agencia Estatal Consejo Superior de Investigaciones Científicas - CSIC, Madrid, España.
Anim Reprod. 2025 Aug 5;22(3):e20250049. doi: 10.1590/1984-3143-AR2025-0049. eCollection 2025.
embryo production (IVEP) offers an alternative approach for fertility preservation, genetic improvement, and reproductive research. However, , the female reproductive tract constitutes a dynamic microenvironment that undergoes critical changes crucial to support oocyte maturation, fertilization and embryo development. During IVEP, the absence of maternal-gamete and later maternal-embryo cross-talk can compromises both fertility and embryo development as well as quality. Extracellular vesicles (EVs) derived from the maternal reproductive tract, such as those from follicular fluid, oviductal fluid and uterine fluid, have attracted increasing attention due to their ability to carry bioactive biomolecules and partially restore this bidirectional communication when supplemented during IVEP. Moreover, EVs hold the potential to serve as indicator of the physiological or pathological state of reproductive structures as well as serving as real-time biomarkers. In addition, several studies suggest that EVs offer multiples advantages over conventional synthetics carries, opening new frontiers for modern drug or nucleotide delivery systems. Therefore, this review aims to provide a comprehensive overview of EVs derived from female reproductive tract, exploring their potential applications and challenges in enhancing IVEP outcomes and fertility treatments.
胚胎生产(体外胚胎生产,IVEP)为生育力保存、遗传改良和生殖研究提供了一种替代方法。然而,雌性生殖道构成了一个动态微环境,会经历对支持卵母细胞成熟、受精和胚胎发育至关重要的关键变化。在体外胚胎生产过程中,母源配子与后期母胎之间缺乏相互作用会损害生育力、胚胎发育以及胚胎质量。源自母体生殖道的细胞外囊泡(EVs),如卵泡液、输卵管液和子宫液中的细胞外囊泡,因其能够携带生物活性生物分子,并在体外胚胎生产过程中补充时部分恢复这种双向交流而受到越来越多的关注。此外,细胞外囊泡有潜力作为生殖结构生理或病理状态的指标,以及作为实时生物标志物。此外,多项研究表明,与传统合成载体相比,细胞外囊泡具有多种优势,为现代药物或核苷酸递送系统开辟了新的领域。因此,本综述旨在全面概述源自雌性生殖道的细胞外囊泡,探讨它们在提高体外胚胎生产结果和生育治疗方面的潜在应用和挑战。